ipopba

ipopba

InMed Pharmaceuticals (NASDAQ:INM) Friday announced the appointment of Netta Jagpal as Chief Financial Officer and Corporate Secretary, effective February 20. Jagpal joins InMed with over 20 years of experience in financial leadership roles, primarily in the biotech industry. Prior to InMed, Jagpal served as Vice President, Financial Reporting & Compliance for D-Wave Systems (QBTS).

InMed Pharmaceuticals（NASDAQ:INM）周五宣布任命Netta Jagpal为首席财务官和公司秘书，自2月20日起生效。Jagpal加入InMed拥有20多年的财务领导经验，主要是在生物技术行业。在加入InMed之前，Jagpal曾担任D-Wave Systems（QBTS）财务报告与合规部副总裁。

Source: Press Release.

来源：新闻稿。

More on InMed Pharmaceuticals Historical earnings data for InMed Pharmaceuticals Financial information for InMed Pharmaceuticals

有关InMed Pharmaceuticals的更多信息InMed Pharmaceuticals的历史收益数据InMed Pharmaceuticals的财务信息